<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05061082</url>
  </required_header>
  <id_info>
    <org_study_id>UMCHoChiMinhCity</org_study_id>
    <nct_id>NCT05061082</nct_id>
  </id_info>
  <brief_title>Genomic Evolution of Metastasis in Gastric Cancer</brief_title>
  <official_title>Genomic Evolution of Metastasis in Gastric Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Ho Chi Minh City (UMC)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Center Ho Chi Minh City (UMC)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to track tumor evolution of regional and distant metastases in&#xD;
      gastric cancer using the Next Generation Sequencing technologies.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gastric cancer is the fourth most common cancer in Vietnam with high mortality rate.&#xD;
      Metastasis is the leading cause of death in gastric cancer patients, with median overall&#xD;
      survival of less than 1 year. Currently, there is no effective treatment because the&#xD;
      molecular mechanism of metastasis remains unclear. The aim of this study is to use advanced&#xD;
      NGS technologies to dissect the genomic changes (genetic, epigenetic and transcriptional&#xD;
      changes) of the primary tumor and associated metastatic sites of the same patients. With&#xD;
      that, the investigators can reconstruct the clonal evolution from primary tumor to&#xD;
      metastasis, identify key pathways governing metastasis development that can be targeted for&#xD;
      future therapeutic development.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 26, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Genetic and epigenetic changes of the tumor</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>Ultra-deep NGS of the primary tumor and associated metastatic sites from the same patients to identify mechanism governing metastasis development</description>
  </primary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Gastric Cancer</condition>
  <condition>Metastasis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with metastatic gastric adenocarcinoma&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or Female patients aged 18 years and older&#xD;
&#xD;
          2. Histologically proven primary gastric adenocarcinoma and clinical evidence of&#xD;
             metastasis (N1-3M1)&#xD;
&#xD;
          3. Biopsies can be taken at multiple sites&#xD;
&#xD;
          4. No known other concomitant cancer diagnosis&#xD;
&#xD;
          5. Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Gastric adnocarcinoma cannot be confirmed primary&#xD;
&#xD;
          2. Unable to undergo biopsy or surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Long Duy Vo, MD, PhD</last_name>
    <phone>+84. 918133915</phone>
    <email>long.vd@umc.edu.vn</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Medical Center Ho Chi Minh City</name>
      <address>
        <city>Ho Chi Minh City</city>
        <zip>700000</zip>
        <country>Vietnam</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Long Vo, MD</last_name>
      <phone>+84918133915</phone>
      <email>long.vd@umc.edu.vn</email>
    </contact>
  </location>
  <location_countries>
    <country>Vietnam</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 9, 2021</study_first_submitted>
  <study_first_submitted_qc>September 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2021</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gastric Cancer</keyword>
  <keyword>Metastasis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

